The domestic healthcare system has been able to solve almost all problems related to the novel coronavirus pandemic, head of the National Medical Chamber and co-chairman of the All-Russia People’s Front central headquarters Leonid Roshal said on Monday.
“The state has done the colossal amount of work on COVID-19. <…> More than 90-95% of all issues related to COVID-19 have been resolved,” he told a round table in the All-Russia People’s Front on insurance payments to medical workers who had the novel coronavirus.
Roshal stressed, however, that one should not think that the pandemic is over, adding that it was still important to take preventive measures, for example, wear face masks.
Three Russian companies are to start industrial production of the first coronavirus vaccine in the Russian Federation developed by the Gamaleya National Research Institute of Epidemiology and Microbiology in September, Industry and Trade Minister Denis Manturov said in an interview with TASS.
“The Gamaleya Institute is working on serial production with three enterprises with facilities in the Vladimir, Yaroslavl and Moscow regions, those are Generium, R-Pharm and Binnopharm. <…> We very much hope that serial production will start as early as in September,” he said.
Several thousands of vaccine doses per month are planned to be produced at the initial stage this year, whereas by the beginning of next year companies will increase output to several millions, the minister added.
Header: KRASNODAR, RUSSIA – MARCH 20, 2020: An employee processing samples while conducting COVID-19 coronavirus tests at the Microbiology Lab of the Hygienic and Epidemiological Center in the Krasnodar Territory, part of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor). Igor Onuchin/TASS